ATLAS / Macro Radar / Reporting / NEUP

Neuphoria Therapeutics Inc. (NEUP) reporting calendar

Neuphoria Therapeutics Inc. files periodic reports with the SEC as NEUP on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 8 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 92-day cadence, filed a median 46 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open NEUP market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001193125-26-225442
10-Q31 Dec 202517 Feb 202648 days0001193125-26-054509
10-Q30 Sep 202514 Nov 202545 days0001193125-25-281579
10-K30 Jun 202529 Sep 202591 days0001193125-25-223338
10-Q31 Mar 202520 May 202550 days0000950170-25-075175
10-Q31 Dec 202414 Feb 202545 days0000950170-25-020473
10-Q30 Sep 202414 Nov 202445 days0000950170-24-127032
10-K30 Jun 202430 Sep 202492 days0001213900-24-082909
20-F30 Jun 202318 Oct 2023110 days0000950170-23-053873
20-F30 Jun 202214 Oct 2022106 days0000950170-22-019563

Source: SEC EDGAR company submissions for CIK 0001191070. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.